5 results match your criteria: "The Wuxi Fifth Affiliated Hospital of Jiangnan University[Affiliation]"
Effect of Chinese Medicines combined with transarterial chemoembolization on primary hepatic carcinoma: A systematic review and meta-analysis.
Medicine (Baltimore)
June 2023
Department of Infectious Diseases, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Background: To systematically evaluate the survival rate and postoperative adverse reactions of patients with hepatocellular carcinoma treated with traditional Chinese medicine combined with TACE by meta-analysis.
Methods: Four major literature databases (Cochrane Library, Embase, PubMed, and Web of Science) were retrieved to collect published English articles since 2009. After determining the random effect model or fixed utility model based on a heterogeneity test, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
IL-21 Is Associated With Virological Relapse of HBeAg Positive Chronic Hepatitis B After Discontinuance of Entecavir.
Turk J Gastroenterol
February 2021
Liver Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu Province, China.
Article Synopsis
- - The study examines how interleukin-21 (IL-21) levels relate to the recurrence of hepatitis B virus (HBV) after stopping entecavir treatment in patients with chronic hepatitis B (CHB) who test positive for HBeAg.
- - Blood samples from 112 CHB patients were taken at various intervals after stopping treatment, and results showed that IL-21 levels were significantly higher in patients who maintained durable virological remission compared to those who experienced relapse.
- - The findings suggest that IL-21 levels can serve as an independent indicator for the risk of CHB relapse after treatment discontinuation, highlighting its role in the immune response for patients post-ETV therapy.
RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.
J Gastroenterol Hepatol
October 2020
Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Single-nucleotide polymorphisms of and -induced liver injury in the Han Chinese population.
World J Gastroenterol
March 2020
Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
Article Synopsis
- A study was conducted to investigate single-nucleotide polymorphisms (SNPs) that could indicate a person's susceptibility to herb-induced liver injury (PM-DILI) in China, where this is a significant health issue.
- Researchers analyzed genetic data from 382 participants, including patients with PM-DILI, other types of drug-induced liver injury, and healthy controls, to identify SNPs associated with PM-DILI.
- Results revealed three SNPs, particularly rs1055348, had significantly higher frequencies in PM-DILI patients and may serve as a specific risk factor for this condition, suggesting its potential as a biomarker for both PM-DILI and other drug-induced liver injuries.
Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients.
Int J Infect Dis
February 2016
Department of Infectious Disease, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou 215006, Jiangsu Province, China. Electronic address:
Objectives: To assess off-treatment virological relapse rates and to determine the role of hepatitis B surface antigen (HBsAg) quantification in predicting virological relapse after stopping entecavir (ETV) treatment in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB).
Methods: One hundred and twelve CHB patients for whom ETV was stopped in accordance with the Asian Pacific Association for the Study of the Liver guidelines stopping rules were enrolled. Patient HBsAg and HBV DNA levels were monitored every 4-12 weeks during ETV treatment and after ETV cessation.